RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 10 - per page
Order by
Genus Pharmaceuticals has recently became the wholly owned UK subsidiary of STADA Arzneimittel AG, a German company with a large portfolio of existing generic drugs, as well as an impressive number in its pipeline. More
Committed to finding diagnostic solutions to disease by partnering More
LTS Lohmann Therapie-Systeme AG concentrates its resources on the development and manufacture of transdermal patch and oral wafer technologies More
Dedicated discovery company, leveraging its advantage in this field into collaborative projects in preclinical drug discovery More
A specialty pharmaceutical company focusing on neurology, and concentrating on Parkinson's disease and other movement disorders More
Within large pharmaceutical companies, the marketing and supply chain of long-established products may no longer be optimally managed. This provides a niche for companies that are able to identify the winners in these 'tail end' products. More
Labtec specializes in the development of transdermal drug delivery technologies that can give new life to ethical drugs approaching the end of their patent protection. More
Identifying the best partner for technology or clinical compounds is one of the most time consuming and frustrating aspects of deal making More
APR is a biopharmaceutical company focused on the development of novel delivery systems for highly successful existing drugs. More
Typically, price is the last major decision that is made before the launch of a pharmaceutical product More
Displaying 1..10 of 10 - per page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us